Fukushima Daiichi Nuclear Power Plant Update from IAEA and World Nuclear Association

At 00:00 UTC on 15 March a dose rate of 11.9 millisieverts (mSv) per hour was observed. Six hours later, at 06:00 UTC on 15 March a dose rate of 0.6 millisieverts (mSv) per hour was observed. These observations indicate that the level of radioactivity has been decreasing at the site. As reported earlier, a …

Read more

Grossmont Formation in Alberta Canada With 318 Billion Barrels of Oil in Place Could Start Producing in 2013 to 2015

Ad Support : Nano Technology   Netbook    Technology News    Computer Software Canada’s next big resource play could very well turn out to be The Grosmont, a bitumen-rich heavy-oil resource in the Grosmont formation of northern Alberta. The formation and its potential has been known to the energy industry since the 1970s, but the technology to develop it …

Read more

Net 12.7 Megajoules Generated During Impact, Quench and Initial Ignition Phase Per Shot of Methane Impact Fusion

Ad Support : Nano Technology   Netbook    Technology News    Computer Software One millimeter of diamond methane can be accelerated to 1000 kilometers per second to produce fusion. The diamond methane impact fusion work is computer simulations and research papers now. Only the initial impact and ignition have been simulated in detail, but even that part is showing …

Read more

Eyeglass Viewing With 67 Inch Equivalent 2D and 3D Screen for $350

Vuzix Wrap 920 video eyewear is a sunglass-style display that delivers a virtual 67-inch screen as seen from 10ft away, displays 2D and 3D video and is claimed to be the most advanced wearable display available. * removable noise-isolating earbuds * an adjustable nose bridge * weighs less than 3 ounces * Two AA batteries …

Read more

Gene Therapy Success Blocking Virus Replication and Stem Cell Successes

A Danish drug tested on San Antonio chimpanzees is showing promise as a new gene-based therapy that fights hepatitis C and potentially other diseases. The drug, developed by biopharmaceutical firm Santaris Pharma doesn’t directly fight the virus, which is quick to develop drug resistance. Instead, it targets and locks down a gene in the liver …

Read more